Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 30,578 | 19,820 | 15,029 | 12,977 | 13,186 |
| Operating Income | -30,578 | -19,820 | -15,029 | -12,977 | -13,186 |
| Other Income | 5,898 | 5,915 | 7,186 | 1,386 | 843 |
| Pre-tax Income | -24,680 | -13,905 | -7,843 | -11,590 | -12,343 |
| Income Tax | 79 | 70 | 44 | 29 | 10 |
| Net Income Continuous | -24,759 | -13,975 | -7,887 | -11,619 | -12,353 |
| Minority Interests | -492 | -302 | -450 | -2,193 | -2,214 |
| Net Income | $-24,267 | $-13,673 | $-7,437 | $-9,426 | $-10,139 |
| EPS Basic Total Ops | -0.39 | -0.22 | -0.09 | -0.18 | -0.23 |
| EPS Basic Continuous Ops | -0.39 | -0.22 | -0.08 | -0.22 | -0.28 |
| EPS Diluted Total Ops | -0.39 | -0.22 | -0.09 | -0.18 | -0.23 |
| EPS Diluted Continuous Ops | -0.39 | -0.22 | -0.08 | -0.22 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.22 | -0.12 | N/A | N/A |
| EBITDA(a) | $-30,236 | $-19,492 | $-14,669 | $-12,974 | $-13,183 |